Data from more than 13,000 patients with AF show that the use of edoxaban over four years is associated with a low annualised rate of all-cause death, ischaemic stroke and major bleeding. 1, 2 The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results